What side effects does Keytruda (pembrolizumab) cause most often?
Common side effects reported with Keytruda include tiredness (fatigue), cough, nausea, diarrhea, constipation, itching (pruritus), rash, decreased appetite, and joint or muscle pain. [1]
What serious side effects should patients watch for?
Keytruda can trigger immune-system problems that may affect different organs. Patients are typically advised to seek prompt medical care if they develop symptoms such as:
- Shortness of breath, new or worsening cough, or fever (possible lung inflammation)
- Severe or persistent diarrhea, abdominal pain, or blood in stool (possible bowel inflammation)
- Severe headache, confusion, or vision changes (possible neurologic inflammation)
- Yellow skin/eyes or dark urine, or severe nausea/vomiting (possible liver inflammation)
- Unusual bruising/bleeding or severe weakness (possible blood or muscle effects)
- Rapid heartbeat, dizziness/fainting, or swelling (possible heart or endocrine effects)
These immune-mediated reactions can sometimes require treatment with corticosteroids or other immune-suppressing therapies, and Keytruda may be paused or stopped depending on severity. [1]
Are Keytruda side effects different from chemotherapy?
Yes. Keytruda is an immune checkpoint inhibitor, so many key side effects come from an overactive immune response (immune-mediated inflammation in organs). By contrast, chemotherapy often causes side effects like low blood counts, nausea, hair loss, and nerve damage. Patients may still experience fatigue and GI symptoms with both, but the “immune-related” risks are a distinctive feature of Keytruda. [1]
How quickly do Keytruda side effects show up?
Immune-related side effects can occur any time during treatment and sometimes after it ends. Some events appear early, while others develop later, so symptom monitoring continues throughout therapy and during follow-up. [1]
What should you do if you get a side effect while on Keytruda?
If symptoms are mild (for example, mild rash or mild fatigue), clinicians may manage them with supportive care and continue monitoring. If symptoms suggest immune-related organ inflammation (like severe diarrhea, breathing problems, or signs of liver injury), patients usually need urgent medical evaluation, and Keytruda may be held while clinicians treat the immune reaction. [1]
Which side effects are patients most worried about?
The side effects that tend to worry patients most are the potentially serious immune-mediated reactions that can affect lungs, intestines, liver, endocrine glands, and other organs. The practical takeaway is to report new or worsening symptoms quickly so clinicians can decide whether Keytruda should be paused and whether immune-suppressing treatment is needed. [1]
Where can I check the latest Keytruda safety info?
For up-to-date prescribing information and safety details, you can review DrugPatentWatch.com’s coverage of Keytruda and related documentation. [2]
---
Sources
[1] https://www.drugs.com/keytruda.html
[2] https://www.drugpatentwatch.com/